Re: A couple Q2 events for Zenith
|
3
|
Zenith Epigenetics
|
May 09, 2017 11:05PM
|
Re: Games being played on the share price
|
3
|
Resverlogix Corp.
|
May 01, 2019 08:35PM
|
Re: Resverlogix presenting at Vascular Discovery 2019 next week
|
3
|
Resverlogix Corp.
|
May 16, 2019 10:57AM
|
Re: Posters out
|
3
|
Resverlogix Corp.
|
May 16, 2019 11:15AM
|
Re: RVX MATERIAL CHANGE REPORT
|
3
|
Resverlogix Corp.
|
Jul 23, 2015 02:11PM
|
Re: empagliflozin - a drug competitive to rvx-208???
|
3
|
Resverlogix Corp.
|
Nov 08, 2015 09:47PM
|
Re: CKD Reata / Market Cap
|
3
|
Resverlogix Corp.
|
May 04, 2019 11:34AM
|
Resverlogix Repays $68.8 Million Loan
|
3
|
Resverlogix Corp.
|
Dec 06, 2017 07:49PM
|
Zenith Keystone Talk, Tues 3/19
|
3
|
Zenith Epigenetics
|
Mar 15, 2019 01:51PM
|
Re: BET inhibitor and BRD4 papers keep piling up
|
3
|
Resverlogix Corp.
|
Sep 25, 2017 10:36AM
|
Re: Clarification received...
|
3
|
Resverlogix Corp.
|
Jun 10, 2018 12:02AM
|
A busy four days coming up
|
3
|
Resverlogix Corp.
|
Mar 15, 2019 01:59PM
|
Re: New publications
|
3
|
Resverlogix Corp.
|
Oct 09, 2015 10:16AM
|
Re: Can the Experts on this Forum tell us if this is credible?
|
3
|
Resverlogix Corp.
|
Mar 21, 2020 11:30PM
|
BIO Europe
|
3
|
Zenith Epigenetics
|
Oct 28, 2018 08:34AM
|
Re: Wow – I expect so much more from RVX professionals…
|
3
|
Resverlogix Corp.
|
Jun 09, 2017 10:46AM
|
Zacks SCR Report 12/20/2017
|
4
|
Resverlogix Corp.
|
Dec 23, 2017 08:43AM
|
Re: Patent Applications in U.S. and Europe
|
4
|
BIOASIS TECHNOLOGIES INC
|
Jun 25, 2019 06:55AM
|
Re: Article Mentioning Apabetalone
|
4
|
Resverlogix Corp.
|
Jun 22, 2018 10:58AM
|
Re: An email and response from another poster.
|
4
|
Resverlogix Corp.
|
Dec 04, 2018 09:34PM
|